The combinatorial expression of WWTR1, MAF1 and RIN1 modestly improved the ability to predict metastasis free survival in BC patients (p = 0.0029, Concordance Index = 59.88, Risk Groups Hazard Ratio = 3.54). Here, MAF1 is linked to breast cancer.